In 2016, bi-allelic mutations in SLC39A14 were identified in individuals with features of Mn neurotoxicity, such as rapidly progressing dystonia, variable parkinsonism, and T1 hyperintensity in the globus pallidus observed on brain MRI [45]. This evidence concerns the gene SLC39A14 and Parkinsonism.